Earnings Feed
Start Free
LIXTE BIOTECHNOLOGY HOLDINGS, INC.·4

Jul 2, 4:06 PM ET

Yen Yun 4

4 · LIXTE BIOTECHNOLOGY HOLDINGS, INC. · Filed Jul 2, 2021

Insider Transaction Report

Form 4
Period: 2021-06-30
LIXTE BIOTECHNOLOGY HOLDINGS, INC.LIXT
Yen Yun
Director
Transactions
  • Award

    Options to Purchase Common Stock

    2021-06-30+100,000→ 100,000 total
    Exercise: $3.03From: 2021-06-30Exp: 2026-06-30→ Common (100,000 underlying)
Holdings

  • Warrants to Purchase Common Stock

    (indirect: By Sino-American Cancer FDD)
    Exercise: $5.70From: 2020-11-30Exp: 2025-11-30→ Common (52,632 underlying)
    52,632

  • Options to Purchase Common Stock

    Exercise: $3.21From: 2021-01-06Exp: 2026-01-06→ Common (50,000 underlying)
    50,000

  • Options to Purchase Common Stock

    Exercise: $1.68From: 2018-08-04Exp: 2023-08-04→ Common (33,333 underlying)
    33,333

  • Options to Purchase Common Stock

    Exercise: $6.60From: 2019-05-22Exp: 2024-05-22→ Common (8,333 underlying)
    8,333
Footnotes (1)
  • [F1]Effective June 30, 2021, the reporting person was granted stock options to purchase an aggregate of 100,000 shares, vesting in eight equal installments on the last day of each subsequent quarter until fully vested (e.g. vesting to start on September 20, 2021).

Documents

1 file
  • 4
    ownership.xmlPrimary